Healthy AdultsNCT04759612
Is Self-action Observation More Effective Than Observing Another Person's Action?
A study testing Action Observation in people with Healthy Adults, run by Dokuz Eylul University at 1 site in Turkey (Türkiye).
Trial summary
The aim of the study is to compare the possible effects of self-action observation and observation of another person's action on upper extremity functionality, cognitive functions and reaction times. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Healthy Adults
- What is being tested?
- Action Observation
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 36 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 4 Jun 2021to 1 Sep 2021
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- >18 years old
- willingness
Who cannot join
- any kind of neurological or musculoskeletal problems
- sight problems
- pain in the upper limb
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Is Self-action Observation More Effective Than Observing Another Person's Action During Upper Extremity Functions?
The aim of the study is to compare the possible effects of self-action observation and observation of another person's action on upper extremity functionality, cognitive functions and reaction times.
- Conditions
- Healthy Adults
- Being tested
- Action Observation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Action ObservationOther
Participants will watch an upper extremity functionality test.
| Study group | Role | What they receive |
|---|---|---|
| Self-Action Observation (s-AO Group) | Experimental | Participants will watch their own actions during an upper extremity functionality test. Receives: Other: Action Observation |
| Action Observation (AO Group) | Experimental | Participants will watch another person's actions during an upper extremity functionality test. Receives: Other: Action Observation |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in upper extremity functionality
Jebsen-Taylor Hand Function Test will be used
Measured: The outcome will be assessed at baseline and immediately after the intervention.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Feb 2021
- Study start4 Jun 2021
- Primary completion16 Aug 2021
- Study completion1 Sep 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Healthy AdultsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Screening
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 36 participants (actual)
Sponsor and investigators
- Lead sponsor
- Dokuz Eylul University
- Sponsor type
- University, hospital or other
- Collaborators
- Izmir Katip Celebi University
- Responsible party
- Principal investigator, Yusuf EMUK, Izmir Katip Celebi University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04759612
- Sponsor's protocol ID
- Katip Celebi University
- Status last verified
- Aug 2022
- First submitted
- 5 Feb 2021
- Last updated
- 3 Aug 2022
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 Aug 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Is Self-action Observation More Effective Than Observing Another Person's Action During Upper Extremity Functions?
- ClinicalTrials.gov ID
- NCT04759612
- Acronym / sponsor ID
- Katip Celebi University
- Conditions
- Healthy Adults
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 36 participants (actual)
- Lead sponsor
- Dokuz Eylul UniversityUniversity, hospital or other
- Collaborators
- Izmir Katip Celebi University
- Study start
- 4 Jun 2021 (actual)
- Primary completion
- 16 Aug 2021 (actual)
- Study completion
- 1 Sep 2021 (actual)
- First posted
- 18 Feb 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of the study is to compare the possible effects of self-action observation and observation of another person's action on upper extremity functionality, cognitive functions and reaction times.
Study design
- Primary purpose
- Screening
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Self-Action Observation (s-AO Group) | Experimental | Other: Action ObservationParticipants will watch their own actions during an upper extremity functionality test. |
| Action Observation (AO Group) | Experimental | Other: Action ObservationParticipants will watch another person's actions during an upper extremity functionality test. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- >18 years old
- willingness
Key exclusion criteria (3 listed)
- any kind of neurological or musculoskeletal problems
- sight problems
- pain in the upper limb
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Action ObservationParticipants will watch an upper extremity functionality test. | Other | Action Observation (AO Group), Self-Action Observation (s-AO Group) |
Primary outcome
Change in upper extremity functionality
Time frame: The outcome will be assessed at baseline and immediately after the intervention.
Jebsen-Taylor Hand Function Test will be used
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Aug 2022.
- Individual participant dataSharing planned: No
Related trials for Healthy Adults
Active, not recruitingPhase 1
A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the Body of Healthy Adults
Healthy
Active, not recruiting
Vascular Aging and Lp299v Study in Healthy Adults
Vascular Aging
Not yet recruitingObservational study
Ultra-high-performance Positron Emission Tomography (PET) of Synaptic Density, Reactive Astrogliosis and Tau in Alzheimer's Disease
Alzheimer's Disease, Healthy Adult Participants
Not yet recruitingPhase 1
Safety and Immunogenicity of Chimeric Hemagglutinin mRNA Vaccine Candidates
Influenza
RecruitingPhase 1
A Study to Evaluate Different Oral Formulations of KT-621
Healthy Participants
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Action Observation in people with Healthy Adults, run by Dokuz Eylul University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 3 Aug 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in upper extremity functionality (time frame: The outcome will be assessed at baseline and immediately after the intervention.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Aug 2022.